MeiraGTx Holdings (MGTX) EBITDA (2017 - 2025)
MeiraGTx Holdings (MGTX) reported EBITDA of $23.8 million for Q4 2025, up 162.21% on a YoY basis from $9.1 million in Q4 2024, and up 148.29% quarter-over-quarter from -$49.3 million in Q3 2025.
MeiraGTx Holdings (MGTX) EBITDA (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported EBITDA for 9 years, with the latest figure at $23.8 million in Q4 2025.
- For the quarter ending Q4 2025, EBITDA rose 162.21% year-over-year to $23.8 million; the trailing twelve-month figure through Dec 2025 stood at -$108.1 million (up 27.99% YoY), and the FY2025 full-year result was -$108.1 million, up 27.99% from the prior year.
- EBITDA for Q4 2025 stood at $23.8 million, up from -$49.3 million in the prior quarter.
- The five-year high for EBITDA was $23.8 million in Q4 2025, with the low at -$49.3 million in Q3 2025.
- Historically, EBITDA has averaged -$27.4 million across 5 years, with a median of -$30.6 million in 2022.
- Annual changes were most pronounced in 2024 — EBITDA tumbled 429.35% — and 2025, when it jumped 162.21%.
- MeiraGTx Holdings' EBITDA stood at -$9.7 million in 2021, then slumped by 278.81% to -$36.7 million in 2022, then jumped by 131.7% to $11.6 million in 2023, then plunged by 429.35% to -$38.3 million in 2024, then surged by 162.21% to $23.8 million in 2025.
- The last three EBITDA figures came in at $23.8 million (Q4 2025), -$49.3 million (Q3 2025), and -$41.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 23.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.81 Mn |
| Sep 30, 2025 | -49.30 Mn |
| Jun 30, 2025 | -41.25 Mn |
| Mar 31, 2025 | -41.33 Mn |
| Dec 31, 2024 | -38.27 Mn |
| Sep 30, 2024 | -40.56 Mn |
| Jun 30, 2024 | -49.11 Mn |
| Mar 31, 2024 | -22.13 Mn |
| Dec 31, 2023 | 11.62 Mn |
| Sep 30, 2023 | -38.29 Mn |
| Jun 30, 2023 | -32.12 Mn |
| Mar 31, 2023 | -32.72 Mn |
| Dec 31, 2022 | -36.66 Mn |
| Sep 30, 2022 | -28.51 Mn |
| Jun 30, 2022 | -26.62 Mn |
| Mar 31, 2022 | -29.11 Mn |
| Dec 31, 2021 | -9.68 Mn |
| Sep 30, 2021 | -23.28 Mn |
| Jun 30, 2021 | -20.49 Mn |
| Mar 31, 2021 | -23.89 Mn |